Interestingly, patients from class III, with nodular sclerosis, showed sharply increase in CCL21 mRNA expression compared with patients from class II (mild or severe mesangial expansion) and IV (advanced diabetic glomerulosclerosis) (Fig. 3B). Here, CCL21 is linked to Hodgkins lymphoma.